These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35397617)

  • 1. HECTD3 promotes gastric cancer progression by mediating the polyubiquitination of c-MYC.
    Zhang G; Zhu Q; Yan X; Ci M; Zhao E; Hou J; Wan S; Lü M; Cui H
    Cell Death Discov; 2022 Apr; 8(1):185. PubMed ID: 35397617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3 ubiquitin ligase HECTD3 is a tumor suppressor and mediates the polyubiquitination of SLC7A11 to promote ferroptosis in colon cancer.
    Huang F; Huang Z; Wei Q; Liu G; Pu J
    Exp Cell Res; 2023 Sep; 430(1):113697. PubMed ID: 37422058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HECTD3 regulates the tumourigenesis of glioblastoma by polyubiquitinating PARP1 and activating EGFR signalling pathway.
    Zhang G; Tan R; Wan S; Yang R; Hu X; Zhao E; Ding X; Zhang J; Li B; Liang P; Cui H
    Br J Cancer; 2022 Nov; 127(11):1925-1938. PubMed ID: 36088509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HECTD3 E3 ubiquitin ligase facilitates cancer cell survival by promoting K63-linked polyubiquitination of caspase-8.
    Li Y; Kong Y; Zhou Z; Chen H; Wang Z; Hsieh YC; Zhao D; Zhi X; Huang J; Zhang J; Li H; Chen C
    Cell Death Dis; 2013 Nov; 4(11):e935. PubMed ID: 24287696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HECTD3 E3 ubiquitin ligase suppresses cisplatin-induced apoptosis via stabilizing MALT1.
    Li Y; Chen X; Wang Z; Zhao D; Chen H; Chen W; Zhou Z; Zhang J; Zhang J; Li H; Chen C
    Neoplasia; 2013 Jan; 15(1):39-48. PubMed ID: 23358872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-153 promotes breast cancer cell apoptosis by targeting HECTD3.
    Wu X; Li L; Li Y; Liu Z
    Am J Cancer Res; 2016; 6(7):1563-71. PubMed ID: 27508098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation.
    Cho JJ; Xu Z; Parthasarathy U; Drashansky TT; Helm EY; Zuniga AN; Lorentsen KJ; Mansouri S; Cho JY; Edelmann MJ; Duong DM; Gehring T; Seeholzer T; Krappmann D; Uddin MN; Califano D; Wang RL; Jin L; Li H; Lv D; Zhou D; Zhou L; Avram D
    Nat Commun; 2019 Feb; 10(1):701. PubMed ID: 30741923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection.
    Li F; Li Y; Liang H; Xu T; Kong Y; Huang M; Xiao J; Chen X; Xia H; Wu Y; Zhou Z; Guo X; Hu C; Yang C; Cheng X; Chen C; Qi X
    J Clin Invest; 2018 Aug; 128(9):4148-4162. PubMed ID: 29920190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between syntaxin 8 and HECTd3, a HECT domain ligase.
    Zhang L; Kang L; Bond W; Zhang N
    Cell Mol Neurobiol; 2009 Feb; 29(1):115-21. PubMed ID: 18821010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara.
    Yu J; Lan J; Zhu Y; Li X; Lai X; Xue Y; Jin C; Huang H
    Biochem Biophys Res Commun; 2008 Mar; 367(4):805-12. PubMed ID: 18194665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E3 ligase HECTD3 promotes esophageal squamous cell carcinoma (ESCC) growth and cell survival through targeting and inhibiting caspase-9 activation.
    Li Y; Wu X; Li L; Liu Y; Xu C; Su D; Liu Z
    Cancer Lett; 2017 Sep; 404():44-52. PubMed ID: 28716524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of HECTD3 by HER2 inhibition makes serous ovarian cancer cells sensitive to platinum treatment.
    Shu T; Li Y; Wu X; Li B; Liu Z
    Cancer Lett; 2017 Dec; 411():65-73. PubMed ID: 28989055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HELZ2 promotes K63-linked polyubiquitination of c-Myc to induce retinoblastoma tumorigenesis.
    Dai H; Zeng W; Zeng W; Yan M; Jiang P; Li Y; Zhang W; Ke M
    Med Oncol; 2021 Nov; 39(1):11. PubMed ID: 34761308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HECTD3 Mediates an HSP90-Dependent Degradation Pathway for Protein Kinase Clients.
    Li Z; Zhou L; Prodromou C; Savic V; Pearl LH
    Cell Rep; 2017 Jun; 19(12):2515-2528. PubMed ID: 28636940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E3 ligase Nedd4l promotes antiviral innate immunity by catalyzing K29-linked cysteine ubiquitination of TRAF3.
    Gao P; Ma X; Yuan M; Yi Y; Liu G; Wen M; Jiang W; Ji R; Zhu L; Tang Z; Yu Q; Xu J; Yang R; Xia S; Yang M; Pan J; Yuan H; An H
    Nat Commun; 2021 Feb; 12(1):1194. PubMed ID: 33608556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E3 ubiquitin ligase HectD3 attenuates cardiac hypertrophy and inflammation in mice.
    Rangrez AY; Borlepawar A; Schmiedel N; Deshpande A; Remes A; Kumari M; Bernt A; Christen L; Helbig A; Jungmann A; Sossalla S; Tholey A; Müller OJ; Frank D; Frey N
    Commun Biol; 2020 Oct; 3(1):562. PubMed ID: 33037313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E3 Ubiquitin Ligase RLIM Negatively Regulates c-Myc Transcriptional Activity and Restrains Cell Proliferation.
    Gao R; Wang L; Cai H; Zhu J; Yu L
    PLoS One; 2016; 11(9):e0164086. PubMed ID: 27684546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The zinc-finger protein ZCCHC2 suppresses retinoblastoma tumorigenesis by inhibiting HectH9-mediated K63-linked polyubiquitination and activation of c-Myc.
    Dai H; Yan M; Li Y
    Biochem Biophys Res Commun; 2020 Jan; 521(2):533-538. PubMed ID: 31677785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Necrosis Factor Receptor-Associated Factor 6 Promotes Hepatocarcinogenesis by Interacting With Histone Deacetylase 3 to Enhance c-Myc Gene Expression and Protein Stability.
    Wu H; Yang TY; Li Y; Ye WL; Liu F; He XS; Wang JR; Gan WJ; Li XM; Zhang S; Zhao YY; Li JM
    Hepatology; 2020 Jan; 71(1):148-163. PubMed ID: 31155734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
    Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
    FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.